# Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene

> **NCT06814431** · — · RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 3000 (estimated)

## Conditions studied

- Idiopathic Parkinson's Disease (PD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06814431
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-23
- **Primary completion:** 2025-12
- **Final completion:** 2026-09
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814431, "Study on the Incidence of Malignant Neoplasms in Patients with Parkinson's Disease and Heterozygous Mutation of the GBA Gene". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06814431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*